Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype Clinical Trials

11 clinical trials for Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype across international registries, including 7 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma — RECRUITING · PHASE1
• A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma — RECRUITING · PHASE1
• TTFields Plus FET-PET-Guided Stereotactic Radiosurgery Versus TTFields Alone for Recurrent Glioblastoma (Tarrget 2.0) — RECRUITING · NA
• Clinical Study on the Safety and Immunogenicity of Specific Cancer Vaccines in Preventing Recurrence of Glioblastoma — RECRUITING · PHASE1
• Feasibility of ONCOhabitats for Surgical and Treatment Planning in IDH-Wildtype Glioblastoma (SINUE) — RECRUITING
• Study of Metabolic, Transcriptomic and Proteomic Characteristics in Relapsed Glioblastoma — RECRUITING
• Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma or Astrocytoma — RECRUITING · PHASE1
• Laser Interstitial Thermal Therapy (LiTT) With Cemiplimab or Other Chemotherapy in Recurrent Glioblastomas — NOT_YET_RECRUITING · PHASE2
• The GLIOMAX Study: MT027 Allogeneic CAR-T for Recurrent Glioma — NOT_YET_RECRUITING · PHASE2
• Study of Niacin in Glioblastoma — SUSPENDED · PHASE1
• BIOhabitats: Biological Validation of Vascular Habitats Within Astrocytoma Grade 4 at Molecular, Cellular, and Histopathological Levels — COMPLETED

Refine this search